See how company executives and directors have been buying or selling shares over the past 30 days. Insider trading activity can help investors better understand company leadership's actions.
No Insider Transactions found for Greenwich LifeSciences, Inc.
Browse insider buying and selling activity reported to the SEC over the past year, including who traded, when they traded, and the value of each transaction.
DATE INSIDER |
INSIDER | TYPE | SHARES | PRICE | SHARES PRICE VALUE |
|---|---|---|---|---|---|
Jul 29, 2026 Patel Snehal |
Patel Snehal
|
Buy |
700 | $13.10 | 700 $13.10 $9,170 |
Jul 28, 2026 Patel Snehal |
Patel Snehal
|
Buy |
1,500 | $13.59 | 1,500 $13.59 $20,385 |
Jul 27, 2026 Patel Snehal |
Patel Snehal
|
Buy |
1,500 | $13.62 | 1,500 $13.62 $20,430 |
Jul 24, 2026 Patel Snehal |
Patel Snehal
|
Buy |
1,100 | $12.88 | 1,100 $12.88 $14,168 |
Jul 23, 2026 Patel Snehal |
Patel Snehal
|
Buy |
2,500 | $13.14 | 2,500 $13.14 $32,850 |
Jan 13, 2026 Patel Snehal |
Patel Snehal
CEO and CFO
|
Buy |
1,800 | $29.83 | 1,800 $29.83 $53,694 |
Jan 12, 2026 Patel Snehal |
Patel Snehal
CEO and CFO
|
Buy |
2,900 | $27.54 | 2,900 $27.54 $79,866 |
Dec 31, 2025 Patel Snehal |
Patel Snehal
CEO and CFO
|
Buy |
4,300 | $21.36 | 4,300 $21.36 $91,848 |
Dec 30, 2025 Patel Snehal |
Patel Snehal
CEO and CFO
|
Buy |
2,900 | $21.73 | 2,900 $21.73 $63,017 |
Dec 18, 2025 Patel Snehal |
Patel Snehal
CEO and CFO
|
Buy |
4,100 | $12.62 | 4,100 $12.62 $51,742 |
Nov 25, 2025 Patel Snehal |
Patel Snehal
CEO and CFO
|
Buy |
4,600 | $8.37 | 4,600 $8.37 $38,502 |
Nov 07, 2025 Patel Snehal |
Patel Snehal
CEO and CFO
|
Buy |
10,600 | $8.43 | 10,600 $8.43 $89,358 |
View older insider trading records reported to the SEC to research long-term buying and selling trends.
DATE INSIDER |
INSIDER | TYPE | SHARES | PRICE | SHARES PRICE VALUE |
|---|---|---|---|---|---|
Oct 31, 2025 Patel Snehal |
Patel Snehal
CEO and CFO
|
Buy |
2,300 | $9.26 | 2,300 $9.26 $21,298 |
Apr 25, 2025 Patel Snehal |
Patel Snehal
CEO and CFO
|
Buy |
3,600 | $9.88 | 3,600 $9.88 $35,568 |
Apr 17, 2025 Patel Snehal |
Patel Snehal
CEO and CFO
|
Buy |
5,400 | $8.98 | 5,400 $8.98 $48,492 |
Apr 07, 2025 Patel Snehal |
Patel Snehal
CEO and CFO
|
Buy |
3,600 | $9.10 | 3,600 $9.10 $32,760 |
Apr 04, 2025 Patel Snehal |
Patel Snehal
CEO and CFO
|
Buy |
5,500 | $8.73 | 5,500 $8.73 $48,015 |
Jan 10, 2025 Patel Snehal |
Patel Snehal
CEO and CFO
|
Buy |
2,500 | $12.51 | 2,500 $12.51 $31,275 |
Jan 07, 2025 Patel Snehal |
Patel Snehal
CEO and CFO
|
Buy |
1,800 | $13.75 | 1,800 $13.75 $24,750 |
Jan 06, 2025 Patel Snehal |
Patel Snehal
CEO and CFO
|
Buy |
1,100 | $13.31 | 1,100 $13.31 $14,641 |
Jan 03, 2025 Patel Snehal |
Patel Snehal
CEO and CFO
|
Buy |
3,400 | $12.95 | 3,400 $12.95 $44,030 |
Jan 02, 2025 Patel Snehal |
Patel Snehal
CEO and CFO
|
Buy |
2,000 | $11.97 | 2,000 $11.97 $23,940 |
Dec 31, 2024 Patel Snehal |
Patel Snehal
CEO and CFO
|
Buy |
2,400 | $11.36 | 2,400 $11.36 $27,264 |
Dec 30, 2024 Patel Snehal |
Patel Snehal
CEO and CFO
|
Buy |
3,200 | $11.12 | 3,200 $11.12 $35,584 |
Nov 21, 2024 Thompson Jaye |
Thompson Jaye
VP Clinical Reg Affairs
|
Buy |
1,000 | $12.91 | 1,000 $12.91 $12,910 |
Sep 26, 2024 Patel Snehal |
Patel Snehal
CEO and CFO
|
Buy |
1,500 | $14.63 | 1,500 $14.63 $21,945 |
Aug 12, 2024 Thompson Jaye |
Thompson Jaye
VP Clinical Reg Affairs
|
Buy |
800 | $13.85 | 800 $13.85 $11,080 |
Aug 06, 2024 Patel Snehal |
Patel Snehal
CEO and CFO
|
Buy |
2,000 | $13.81 | 2,000 $13.81 $27,620 |
Aug 05, 2024 Patel Snehal |
Patel Snehal
CEO and CFO
|
Buy |
5,500 | $13.18 | 5,500 $13.18 $72,490 |
Aug 02, 2024 Thompson Jaye |
Thompson Jaye
VP Clinical Reg Affairs
|
Buy |
1,000 | $15.15 | 1,000 $15.15 $15,150 |
Jul 23, 2024 Patel Snehal |
Patel Snehal
CEO and CFO
|
Buy |
1,500 | $15.89 | 1,500 $15.89 $23,835 |
Jul 18, 2024 Thompson Jaye |
Thompson Jaye
VP Clinical Reg Affairs
|
Buy |
1,000 | $16.00 | 1,000 $16.00 $16,000 |
TOP
